Trial Profile
An Expanded access trial of RT001 in Late Onset Tay Sachs (LOTS) disease
Status:
Planning
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 15 Jun 2018
Price :
$35
*
At a glance
- Drugs RT 001 (Primary)
- Indications Tay-Sachs disease
- Focus Expanded access; Therapeutic Use
- 15 Jun 2018 New trial record